Ajooni Biotech (AJOONI) | Financial Analysis & Statements
Ajooni Biotech Ltd. Small-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
292.7M
Gross Profit
65.7M
22.46%
Operating Income
9.4M
3.21%
Net Income
15.4M
5.27%
Balance Sheet Metrics
Total Assets
950.5M
Total Liabilities
69.7M
Shareholders Equity
880.8M
Debt to Equity
0.08
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Mar 31, 2025
Annual Income Flow
2025
Ajooni Biotech Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 801.1M | 744.9M | 740.4M | 510.4M |
| Cost of Goods Sold | 970.3M | 703.5M | 657.4M | 640.1M | 430.1M |
| Gross Profit | 176.6M | 97.6M | 87.4M | 100.2M | 80.3M |
| Gross Margin % | 15.4% | 12.2% | 11.7% | 13.5% | 15.7% |
| Operating Expenses | |||||
| Research & Development | 0 | 670.0K | 2.4M | 498.0K | 699.0K |
| Selling, General & Administrative | 81.9M | 32.4M | 20.5M | 28.8M | 32.0M |
| Other Operating Expenses | 22.2M | 18.4M | 13.4M | 19.0M | 15.9M |
| Total Operating Expenses | 104.0M | 51.4M | 36.3M | 48.3M | 48.6M |
| Operating Income | 29.0M | 15.1M | 17.6M | 22.2M | 12.1M |
| Operating Margin % | 2.5% | 1.9% | 2.4% | 3.0% | 2.4% |
| Non-Operating Items | |||||
| Interest Income | 8.9M | 5.0M | 2.0M | 6.0K | 2.1K |
| Interest Expense | 3.0M | 5.5M | 4.7M | 5.4M | 4.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 43.3M | 30.0M | 15.8M | 14.6M | 5.0M |
| Income Tax | 9.6M | 8.3M | 4.5M | 4.1M | 1.3M |
| Effective Tax Rate % | 22.1% | 27.9% | 28.7% | 28.2% | 26.0% |
| Net Income | 33.7M | 21.6M | 11.2M | 10.5M | 3.7M |
| Net Margin % | 2.9% | 2.7% | 1.5% | 1.4% | 0.7% |
| Key Metrics | |||||
| EBITDA | 48.5M | 31.1M | 30.5M | 32.3M | 15.8M |
| EPS (Basic) | ₹0.20 | ₹0.22 | ₹1.51 | ₹0.16 | ₹0.06 |
| EPS (Diluted) | ₹0.20 | ₹0.22 | ₹1.51 | ₹0.16 | ₹0.06 |
| Basic Shares Outstanding | 168600000 | 99371407 | 7460613 | 64999850 | 64348577 |
| Diluted Shares Outstanding | 168600000 | 99371407 | 7460613 | 64999850 | 64348577 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Ajooni Biotech Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 68.3M | 4.3M | 3.1M | 574.0K | 2.4M |
| Short-term Investments | 7.1M | 22.0K | 5.1M | 1.2M | 1.6M |
| Accounts Receivable | 162.2M | 129.6M | 205.5M | 138.4M | 137.1M |
| Inventory | 239.9M | 153.7M | 69.9M | 58.8M | 53.8M |
| Other Current Assets | 12.0M | - | 25.4M | 18.6K | 1.1M |
| Total Current Assets | 620.0M | 323.3M | 346.7M | 219.3M | 214.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 109.3M | 0 | 62.9M | 62.1M | 51.6M |
| Goodwill | 4.8M | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.8M | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 24.0M | - | 15.0M | - | 1.4M |
| Total Non-Current Assets | 330.5M | 151.9M | 240.6M | 70.9M | 66.0M |
| Total Assets | 950.5M | 475.2M | 587.3M | 290.2M | 280.3M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 35.0M | 15.8M | 101.1M | 68.0M | 54.0M |
| Short-term Debt | 0 | 4.9M | 34.3M | 27.7M | 48.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 2.9M | - | 10.4M | 380.0K | 412.0K |
| Total Current Liabilities | 48.2M | 30.1M | 152.1M | 100.6M | 104.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 19.4M | 16.8M | 17.5M | 25.8M | 19.0M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.0K | -5.0K | -1.0K | -1.0K | 301.0K |
| Total Non-Current Liabilities | 21.5M | 18.0M | 18.5M | 25.8M | 19.3M |
| Total Liabilities | 69.7M | 48.1M | 170.6M | 126.4M | 124.1M |
| Equity | |||||
| Common Stock | 344.5M | 175.2M | 175.2M | 100.1M | 100.1M |
| Retained Earnings | - | - | - | - | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 880.8M | 427.1M | 416.7M | 163.8M | 156.2M |
| Key Metrics | |||||
| Total Debt | 19.4M | 21.7M | 51.8M | 53.5M | 67.8M |
| Working Capital | 571.8M | 293.2M | 194.6M | 118.7M | 109.5M |
Balance Sheet Composition
Ajooni Biotech Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 43.3M | 30.0M | 15.8M | 14.6M | 5.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -236.4M | 110.0M | -114.1M | -6.8M | -38.3M |
| Operating Cash Flow | -198.6M | 140.5M | -95.5M | 14.6M | -27.4M |
| Investing Activities | |||||
| Capital Expenditures | 9.6M | 344.0K | -28.6M | 991.0K | -35.3M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -169.5M | - | -131.7M | 0 | - |
| Investment Sales | - | 127.0M | - | 1.3M | - |
| Investing Cash Flow | -159.9M | 127.4M | -160.3M | 2.3M | -34.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 249.0M | -29.4M | 377.5M | -21.1M | 23.9M |
| Free Cash Flow | -197.7M | 173.1M | -84.4M | 15.6M | -23.7M |
| Net Change in Cash | -109.5M | 238.4M | 121.7M | -4.3M | -37.6M |
Cash Flow Trend
Ajooni Biotech Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.30
Price to Book
0.77
Price to Sales
0.48
Profitability Ratios
Profit Margin
3.23%
Operating Margin
3.78%
Return on Equity
5.51%
Return on Assets
3.58%
Financial Health
Current Ratio
3.20
Debt to Equity
11.32
Beta
0.44
Per Share Data
EPS (TTM)
₹0.20
Book Value per Share
₹5.53
Revenue per Share
₹14.79
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AJOONI | 733.8M | 21.30 | 0.77 | 5.51% | 3.23% | 11.32 |
| Nestle India | 2.7T | 76.65 | 60.70 | 76.34% | 15.11% | 8.61 |
| Britannia Industries | 1.4T | 57.14 | 36.97 | 49.73% | 12.84% | 58.42 |
| BN Holdings | 38.6B | 26.71 | 5.01 | 5.05% | 8.31% | 21.23 |
| Cian Agro Industries | 35.7B | 31.81 | 1.76 | 2.04% | 8.08% | 62.05 |
| Gopal Snacks | 34.5B | 839.85 | 7.97 | 4.69% | 0.30% | 14.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.



